NZ201112A - Preparation of a cancer-specific antigen and composition - Google Patents

Preparation of a cancer-specific antigen and composition

Info

Publication number
NZ201112A
NZ201112A NZ201112A NZ20111282A NZ201112A NZ 201112 A NZ201112 A NZ 201112A NZ 201112 A NZ201112 A NZ 201112A NZ 20111282 A NZ20111282 A NZ 20111282A NZ 201112 A NZ201112 A NZ 201112A
Authority
NZ
New Zealand
Prior art keywords
gra
lectin
cancer
cells
cell
Prior art date
Application number
NZ201112A
Other languages
English (en)
Inventor
M Adachi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15641481A external-priority patent/JPS5857321A/ja
Priority claimed from JP56156413A external-priority patent/JPS5857318A/ja
Priority claimed from JP56158473A external-priority patent/JPS5859923A/ja
Priority claimed from JP56158472A external-priority patent/JPS5859922A/ja
Priority claimed from JP57111168A external-priority patent/JPS591420A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NZ201112A publication Critical patent/NZ201112A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NZ201112A 1981-10-01 1982-06-29 Preparation of a cancer-specific antigen and composition NZ201112A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP15641481A JPS5857321A (ja) 1981-10-01 1981-10-01 抗癌剤
JP56156413A JPS5857318A (ja) 1981-10-01 1981-10-01 癌細胞障害性リンパ球の製造法
JP56158473A JPS5859923A (ja) 1981-10-05 1981-10-05 抗癌剤
JP56158472A JPS5859922A (ja) 1981-10-05 1981-10-05 癌細胞障害性リンパ球
JP57111168A JPS591420A (ja) 1982-06-28 1982-06-28 糖鎖関連抗原およびその製造法

Publications (1)

Publication Number Publication Date
NZ201112A true NZ201112A (en) 1986-10-08

Family

ID=27526479

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ201112A NZ201112A (en) 1981-10-01 1982-06-29 Preparation of a cancer-specific antigen and composition

Country Status (19)

Country Link
AR (1) AR230731A1 (forum.php)
AT (2) AT382080B (forum.php)
AU (1) AU554858B2 (forum.php)
BE (1) BE893704A (forum.php)
CA (1) CA1195269A (forum.php)
CH (2) CH655660B (forum.php)
DD (2) DD221917A5 (forum.php)
DE (2) DE3236298A1 (forum.php)
DK (1) DK292182A (forum.php)
FI (1) FI77157C (forum.php)
FR (1) FR2513882B1 (forum.php)
IL (1) IL66270A (forum.php)
IT (1) IT1189305B (forum.php)
MX (1) MX7437E (forum.php)
NL (1) NL8202638A (forum.php)
NO (1) NO161601C (forum.php)
NZ (1) NZ201112A (forum.php)
PT (1) PT75148B (forum.php)
SE (1) SE8204058L (forum.php)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
EP0334300A1 (en) * 1988-03-21 1989-09-27 Neorx Corporation The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
DE1943699A1 (de) * 1969-08-28 1971-03-04 Stiftung Onophrio Heilmittel mit proliferationshemmender Wirkung und Verfahren zur Herstellung dieses Heilmittels
YU34005B (en) * 1970-02-24 1978-10-31 Podvinec Srecko Process for obtaining bovine lymphatic gland extract
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate

Also Published As

Publication number Publication date
SE8204058L (sv) 1983-04-02
DK292182A (da) 1983-04-02
DE3236298A1 (de) 1984-03-15
MX7437E (es) 1988-11-14
NO161601C (no) 1989-09-06
DE3249568C2 (forum.php) 1987-10-01
FI77157C (fi) 1989-02-10
CA1195269A (en) 1985-10-15
IT8248724A1 (it) 1983-12-30
AU554858B2 (en) 1986-09-04
FR2513882B1 (fr) 1986-04-04
AU8545882A (en) 1983-04-14
BE893704A (fr) 1982-10-18
FI822325L (fi) 1983-04-02
DE3249568A1 (de) 1985-02-07
ATA363782A (de) 1986-06-15
CH655660B (forum.php) 1986-05-15
AT390002B (de) 1990-03-12
ATA354585A (de) 1989-08-15
PT75148A (en) 1982-07-01
PT75148B (en) 1986-08-14
IT1189305B (it) 1988-02-04
CH655661B (forum.php) 1986-05-15
AR230731A1 (es) 1984-06-29
FR2513882A1 (fr) 1983-04-08
FI77157B (fi) 1988-10-31
NO822215L (no) 1983-04-05
DD209577A5 (de) 1984-05-16
NL8202638A (nl) 1983-05-02
IT8248724A0 (it) 1982-06-30
AT382080B (de) 1987-01-12
NO161601B (no) 1989-05-29
IL66270A0 (en) 1982-11-30
DD221917A5 (de) 1985-05-08
IL66270A (en) 1986-03-31
DE3236298C2 (forum.php) 1987-09-24
SE8204058D0 (sv) 1982-06-30
FI822325A0 (fi) 1982-06-29

Similar Documents

Publication Publication Date Title
JPH0751511B2 (ja) インターロイキン２を含有してなる癌治療剤
GB2106935A (en) Cancer cell-combatting lymphocytes process, for the production thereof, and anticancer agents containing said lymphocytes
GB2086392A (en) Preparation controlling t-system of immunity and method for producing same
KR20150124880A (ko) 면역질환 치료효과를 갖는 신규한 화합물 및 이의 용도
AU3420689A (en) Method and means for immuno-stimulating blood treatment with a mitogen
NZ201112A (en) Preparation of a cancer-specific antigen and composition
US4849510A (en) Process for preparing glycosidic linkage related antigen
Diederich et al. The effects of mercury and other resgents on Phosphoglycerate mutase− 2, 3− diphosphoglycerate Phosphatase from kidney, muscle and other tissues
CA1201988A (en) Cancer cell-combatting lymphocytes, process for the production thereof and anticancer agents containing said lymphocytes
Klein et al. A murine cytotoxic T lymphocyte clone from the intestinal mucosa that is antigen specific for proliferation and displays broadly reactive inducible cytotoxic activity.
NZ214000A (en) Method of sensitising lymphocytes to cancer associated antigens
FI80711B (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar termiskt denaturerad, till en glykosidbindning ansluten antigen (gra), som haerroer sig fraon cancerceller.
WO1990004633A1 (en) ACTIVATION AND GROWTH OF HUMAN TUMOR-INFILTRATING LYMPHOCYTES USING ANTIBODIES TO CD3 OR TcR
Fisher et al. Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition
US4772469A (en) Production of lymphoid tissue effector cells reactive against cancer cells by means of MER, and use thereof in cancer therapy
KR880001758B1 (ko) 암세포에 대항하는 임파구의 제조방법
GB2079150A (en) Antiviral substance from Basidiomycetes
JPS591420A (ja) 糖鎖関連抗原およびその製造法
CN118726109B (zh) 一株弯颈霉属真菌在抗肿瘤药物中的应用
Bertini et al. A tumour-associated membrane antigen transiently expressed by normal cells during mitosis
NAKAJIMA et al. POLYSACCHARIDE, DMG, A DEGRADED D-MANNO-D-GLUCAN FROM MICROELLOBOSPORIA GRISEA CULTURE FLUID
EP0161384A2 (en) Human endogenous cancer regulatory factors, method of preparing the same, and pharmaceutical compositions containing the same
Pasternak et al. Immunogenicity of soluble extracts from a UV light-induced mouse sarcoma
Roozemond et al. Effect of mycobacterial lipids on membrane fluidity and natural killer cell-mediated cytotoxicity
Hakim Adenocarcinoma‐associated antigen: Enhancement of tumor growth with serum from animals bearing adenocarcinoma